Neurocrine Biosciences
NBIX
#1633
Rank
C$13.89 B
Marketcap
$140.48
Share price
1.28%
Change (1 day)
-23.43%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : C$1.56 Billion

According to Neurocrine Biosciences 's latest financial reports the company's total liabilities are C$1.56 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Neurocrine Biosciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$1.62 B19.82%
2023-12-31C$1.35 B50.77%
2022-12-31C$0.89 B0.74%
2021-12-31C$0.89 B14.73%
2020-12-31C$0.77 B-11.21%
2019-12-31C$0.87 B25.2%
2018-12-31C$0.69 B24.63%
2017-12-31C$0.56 B730.02%
2016-12-31C$67.47 M-3.36%
2015-12-31C$69.81 M75.23%
2014-12-31C$39.84 M9.23%
2013-12-31C$36.47 M-11.84%
2012-12-31C$41.37 M-48.04%
2011-12-31C$79.63 M-36.31%
2010-12-31C$0.12 B77.71%
2009-12-31C$70.35 M-28.92%
2008-12-31C$98.98 M-37.18%
2007-12-31C$0.15 B80.55%
2006-12-31C$87.27 M-19.41%
2005-12-31C$0.10 B-28.09%
2004-12-31C$0.15 B-29.14%
2003-12-31C$0.21 B218.23%
2002-12-31C$66.78 M16.59%
2001-12-31C$57.28 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$1.18 B-24.10%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.91 B 597.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$14.81 M-99.05%๐Ÿ‡บ๐Ÿ‡ธ USA
C$89.30 B 5,608.00%๐Ÿ‡บ๐Ÿ‡ธ USA
C$182.63 B 11,573.78%๐Ÿ‡บ๐Ÿ‡ธ USA
C$173.07 B 10,962.80%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.18 B-24.25%๐Ÿ‡บ๐Ÿ‡ธ USA
C$60.72 M-96.12%๐Ÿ‡บ๐Ÿ‡ธ USA